Cardiac evaluation of chronic obstructive pulmonary disease patients by ECHO and its correlation with different grades of severity of chronic obstructive pulmonary disease
DOI:
https://doi.org/10.18203/2349-3933.ijam20170016Keywords:
COPD, Cardiac dysfunction, EchocardiographyAbstract
Background: COPD is proven to be a multisystem disorder among which cardiac manifestation are most common. Echocardiography provides a rapid, non-invasive, portable, and accurate method to evaluate the cardiac changes. The aim of this study was to assess the cardiac changes secondary to COPD by echocardiography and to find out the correlation between echocardiographic findings and different grades of severity of COPD.
Methods: A total 50 of patients of COPD were selected and staged by spirometry and evaluated by echocardiography.
Results: The numbers of patients with mild, moderate, severe and very severe COPD in our study were 4%, 28%, 58%, and 10%, respectively. On echocardiographic evaluation of COPD, 24% cases had normal echocardiographic parameters. Pulmonary hypertension was observed in 35/50 (70%) cases in which prevalence of mild, moderate, and severe PH were 0%, 50%, 79.3%, and 100%, respectively. Right ventricle was enlarged in ECHO in 46% of patients. Right atrium was enlarged in ECHO in 14% of patients. Measurable tricuspid regurgitation (TR) was observed in 72% cases.
Conclusions: Prevalence of cardiac dysfunction increases as the severity of COPD increases. It is recommended that echocardiography should be done early in all cases of COPD to diagnose the cardiac complications of COPD, so that early interventions can be undertaken in order to improve quality of life and decrease mortality and morbidity in COPD patients.
References
Chesnutt MS, Prendergast TJ, Tavan ET. Pulmonary disorders. In: Papadakis MA, Mcphee SJ, Rabow MW, editors. Current Medical Diagnosis and Treatment.53rd ed, New York: McGraw-Hill Education. 2014:234-314.
Siafakas N, Vermeire P, Pride N, Paoletti P, Gibson J, Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1995;8(8):1398-420.
Macnee W. Chronic bronchitis and emphysema. In: Seaton A, Seaton D, Leitch A, editors. Crofton and Douglas’s Respiratory Diseases. 5th edition. France: Blackwell Science. 2002:616.
Anthonisen N, Connett JE, Kiley JP, Altose MD, Bailey WC. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. JAMA. 1994;272:1497-505.
Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245-57.
Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease, Evaluation and management. Chest. 1991;99:715-23.
Luke SH, Julia G, David D, Michael B, John B. Chambers, Navroz D, et al. Echocardiographic assessment of pulmonary hypertension: standard operating procedure. Eur Respir Rev. 2012;21(125):239-48.
Daniels LB, Krummen DE, Blanchard DG. Echocardiography in pulmonary vascular disease. Cardiol Clin.2004;22:383-99.
Shrestha B, Dhungel S, Chokhani R. Echocardiography based cardiac evaluation in the patients suffering from chronic obstructive pulmonary disease. Nepal Med Coll J. 2009;11(1):14-8.
Suma KR, Srinath S, Praveen. Electrocardiographic and echocardiographic changes in chronic obstructive pulmonary disease (COPD) of different grades of severity. Journal Evolution Medical Dental Sci. 2015;4:5093-101.
Tiwari VK, Agarwal R, Kumar A, Kumar A, Kumar R. The cardiac evaluation in chronic obstructive pulmonary disease patients. Indian J Applied Res. 2015;15(11):434-5.
Jain J, Soni P, Apte S, Chanchlani R. A Study of correlation between echocardiographic changes with the duration and severity of chronic obstructive pulmonary disease. Journal Evolution Med Dental Sci. 2014;3(8):1997-2002.
